Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity

Autoimmunity

Volumn 31, Issue 2, 1999, Pages 117-124

  Jones, Brian M ^a   Liu, Tiefu ^a,b   Wong, Raymond W S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cytokines; Disease activity; ELISPOT; SLE

Indexed keywords

DNA ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0033368154     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908994055     Document Type: Article

References (32)

1. Isenberg, D.A., Dudeney, C., Williams, W., Todd-Popropek, A. and Stollar, B.D. Disease activity in systemic lupus erythematosus related to a range of antibodies binding DNA and synthetic polynucleotides. Ann. Rheum. Dis. 1988; 47: 717-724.
2. Steinberg, A.D., Gourley, M.F., Klinman, D.M., Tsokos, G.C., Scott, D.E. and Kreig, A.M. Systemic lupus erythematosus. Ann. Intern. Med. 1991; 115: 548-559.
3. Ogawa, N., Itoh, M. and Goto, Y. Abnormal production of B-cell growth factor in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 1992; 89: 26-31.
4. Cuadrado, M.J., Marubayashi, M., Ortega, C., Fernandez-Arcas, N., Garcia-Cozar, F., Pena, J. et al. Relationship of IL2, IL2R (CD25), soluble IL2-R and IL4 with disease activity in SLE patients. Lupus 1993; 2: 257-260.
5. Linker-Israeli, M., Deans, R.J., Wallace, D.J., Prehn, J., Ozeri-Chen, T., Klinenberg, J.R. et al. Elevated levels of endogenous IL6 in systemic lupus erythematosus. A putative role in pathogenesis. J. Immunol. 1991; 147: 117-123.
6. Spronk, P., Ter Borg, E., Limburg, P. and Kallenberg, C. Plasma concentrations of IL6 in systemic lupus erythematosus: an indication of disease activity? Clin. Exp. Immunol. 1992; 90: 106-110.
7. Houssiau, F.A., Lefebvre, C., Van den Berghe, M., Lambert, M., Devogelaer, J.P., Goldman, M. et al. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995; 4: 393-395.
8. Studnicka-Benke, A., Steiner, G., Petera, P. and Smolen, J.S. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br. J. Rheumatol. 1996; 35: 1067-1074.
9. Mongan, A.E., Ramdahin, S. and Warrington, R.J. Interleukin-10 response abnormalities in systemic lupus erythematosus. Scand. J. Immunol. 1997; 46: 406-412.
10. al-Janadi, M., al-Balla, S., al-Dalaan, A. and Raziuddin, S. Cytokine profiles in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J. Clin. Immunol. 1993; 13: 58-67.
11. Alcocer-Varela, J., Llorente, L. and Alarcon-Segovia, D. Immunoregulatory circuits and potential treatment of connective tissue diseases. Int. Arch. Allergy Immunol. 1996; 111: 348-354.
12. Richaud-Patin, Y., Alcocer-Varela, J. and Llorente, L. High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev. Invest. Clin. 1995; 47: 267-272.
13. Liu, T.F. and Jones, B.M. Impaired production of IL12 in systemic lupus erythematosus. I. Excessive production of IL10 suppresses production of IL12 by monocytes. Cytokine 1998; 10: 140-147.
14. Liu, T.F. and Jones, B.M. Impaired production of IL12 in systemic lupus erythematosus. II. IL12 production is correlated negatively with serum IL10, positively with serum IFNγ and negatively with disease activity in SLE. Cytokine 1998: 10: 148-153.
15. Hagiwara, E., Gourley, M.F., Lee, S. and Klinman, D.M. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin10:interferon-γ-secreting cells in the peripheral blood. Arth. Rheum. 1996; 39: 379-385.
16. Czerkinsky, C.C., Nilsson, L.A., Nygren, H., Ouchterlony, O. and Tarkowski, A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 1983; 65: 109-121.
17. Sedgwick, J.D. and Holt, P.G. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 1983; 57: 301-309.
18. Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F. et al. The 1982 revision criteria for the classification of systemic lupus erythematosus. Arth. Rheum. 1982; 25: 1271-1277.
19. Bombardier, C., Gladman, D.D., Urowitz, M.B., Caron, D. and Chang, C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. Arth. Rheum. 1992; 35: 630-640.
20. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R.M., Clark, S.C., Chan, S. et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 1989; 170: 827-845.
21. D'Andrea, A., Rengaraju, M., Valiante, N.M., Chehimi, J., Kubin, M., Aste-Amezaga, M. et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 1992; 176: 1387-1398.
22. Maruo, S., Oh-hora, M., Ahn, H.-J., Ono, S., Wysocka, M., Kaneko, Y. et al. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions. J. Immunol. 1997; 158: 120-126.
23. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. and Coffman, R.L. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348-2357.
24. Romagnani, S. The Th1/Th2 paradigm. Immunol. Today 1997; 18: 263-266.
25. + cells. Ann. Rev. Immunol. 1994; 12: 635-673.
26. Kitani, A., Hara, M., Hirose, T., Harigai, M., Suzuki, K., Kawakami, M. et al. Autostimulalory effects of IL6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin. Exp. Immunol. 1992; 88: 75-83.
27. Llorente, L., Richaud-Patin, Y., Wijdenes, J., Alcocer-Varela, J., Maillot, M.C., Durand-Gasselin, I. et al. Spontaneous production of interleukin-10 by B-lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Network 1993; 4: 421-427.
28. Llorente, L., Zou, W., Levy, Y., Richaud-Patin, Y., Wijdenes, J., Alcocer-Varela, J. et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 1995; 181: 839-844.
29. Berger, S., Chandra, R., Ballo, H., Hildenbrand, R. and Stutte, H.J. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur. J. Immunol. 1997; 27: 2994-3000.
30. Moreland, L.W., Baumgartner, S.W., Schiff, M.H., Tindall, E.A., Fleischmann, R.M., Weaver, A.L. et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Eng. J. Med. 1997; 337: 141-147.
31. Liu, T.F., Jones, B.M., Wong, R.W.S. and Srivastava, G. Impaired production of IL-12 in systemic lupus erythematosus. III. Deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFNγ gene expression. Cytokine 1999; 11: (in press).
32. Jones, B.M., Kwok, C.C.H. and Kung, A.W.C. Effect of radioactive iodine therapy on cytokine production in Graves disease: transient increases in inlerleukin-4 (IL-4), IL-6, IL-10 and tumour necrosis factor-α, with longer term increases in interferon-γ production. J. Clin. Endocrinol. Metabol. 1999; 84: (in press).